HRSA Publishes More Stakeholder Comments on Controversial 340B Rebate Pilot Proposal

HRSA has published 1,116 of the 1,243 comments it received on its controversial proposed 340B rebate pilot.
The Health Resources and Services Administration (HRSA) has now published 1,116 of the 1,243 comments it received on its controversial [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

More than 1,200 Stakeholders Comment on HRSA’s Controversial 340B Rebate Pilot

Stakeholders submitted 1,243 comments to HRSA on its contentious 340B rebate pilot program before the Sept. 8 deadline.
The Health Resources and Services Administration (HRSA) received more than 1,200 comments on its controversial 340B rebate pilot program ahead [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Urges HRSA to Abandon 340B Rebate Pilot, Warns of Severe Burdens on Hospitals

AHA General Counsel Chad Golder wrote a letter to HRSA Administrator Thomas Engels urging him to abandon the 340B rebate pilot program.
The American Hospital Association (AHA) is pushing back forcefully against the Health Resources and Services Administration’s (HRSA) new 340B rebate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Remained Strong in the Second Quarter of 2025, Filings Show

340B program stakeholders continued to spend big on federal lobbying efforts in the second quarter of 2025.
The 340B program continued to garner strong lobbying attention on Capitol Hill this spring, despite Congress’ focus on a GOP-backed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: The Time Has Come for NACHC to Withdraw from ASAP 340B 

Ted Slafsky, publisher and CEO, writes a column calling for NACHC to end its 340B-focused alliance with the drug industry trade group PhRMA.
The 340B provider community was rocked two years ago by the announcement of an alliance between the nation’s largest and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Analysis: PhRMA Member Restrictions on Health Centers Have More Than Doubled Since NACHC-PhRMA Alliance Formed

A 340B Report analysis finds that a significant number of PhRMA members placed 340B contract pharmacy restrictions on health centers after the NACHC-PhRMA alliance formed in March 2023.
The number of drugmakers that have placed 340B contract pharmacy restrictions on health centers has more than doubled since the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Patient Groups Back Drugmakers in 340B Rebate Appeal, Without Disclosing Drug Industry Funding or Missed Compliance Deadline

Three patient groups recently told a federal appeals court that a 340B rebate model “is essential to the effort to bring transparency to 340B.” One of those groups did not disclose its financial ties to drugmakers, and another is out of compliance with state public reporting laws.
Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Updates in Colorado, Nebraska

Key briefs were filed in Colorado and Nebraska in ongoing state 340B contract pharmacy litigation.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference

U.S. Rep. Doris Matsui (D-Calif.) and U.S. Sen. Peter Welch (D-Vt.) reintroduced the 340B PATIENTS Act during the 340B Coalition annual summer conference.
The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Consolidates Drugmaker 340B Rebate Appeals, Denies Hospital Group’s Cross-Appeal Request

A federal appeals court in Washington, D.C. consolidated multiple drugmaker appeals in ongoing 340B rebate litigation.
A Washington, D.C. federal appellate court on Friday consolidated multiple drug industry appeals challenging the government’s authority to preapprove 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live